ScholarIQanswers from OpenAlex & ORCID
Sven R. Olson
ResearcherPublications, citations & collaboration network
Sven R. Olson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sven R. Olson have?
ScholarIQindexed works
Sven R. Olson has 74 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sven R. Olson have?
ScholarIQcitation count
Sven R. Olson has 1,905 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sven R. Olson?
ScholarIQh-index
Sven R. Olson has an h-index of 23 in OpenAlex.
What is the i10-index of Sven R. Olson?
ScholarIQi10-index
Sven R. Olson has an i10-index of 35 in OpenAlex.
What is the ORCID of Sven R. Olson?
ScholarIQorcid
The ORCID for Sven R. Olson is on the source record.
What is the OpenAlex record for Sven R. Olson?
ScholarIQopenalex
The OpenAlex for Sven R. Olson is on the source record.
What are the most-cited papers on Sven R. Olson?
ScholarIQmost cited works
Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review
Sven R. Olson, Catherine R. Murphree, David Zonies, Andrew Meyer, Owen J. T. McCarty, Thomas G. DeLoughery, Joseph J. Shatzel
The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients
Johnny Cai, Jessica Ribkoff, Sven R. Olson, Vikram Raghunathan, Hanny Al‐Samkari, Thomas G. DeLoughery, Joseph J. Shatzel
The role of iron repletion in adult iron deficiency anemia and other diseases
Benjamin Elstrott, Lubna Khan, Sven R. Olson, Vikram Raghunathan, Thomas G. DeLoughery, Joseph J. Shatzel
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial
Christina U. Lorentz, Erik I. Tucker, Norah G. Verbout, Joseph J. Shatzel, Sven R. Olson, Brandon D. Markway, Michael Wallisch, Martina Ralle, Monica T. Hinds, Owen J. T. McCarty, David Gailani, Jeffrey I. Weitz, András Gruber
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial
Christina U. Lorentz, Norah G. Verbout, Michael Wallisch, Matthew Hagen, Joseph J. Shatzel, Sven R. Olson, Cristina Puy, Monica T. Hinds, Owen J. T. McCarty, David Gailani, András Gruber, Erik I. Tucker